-
1 Comment
Mani, Inc is currently in a long term downtrend where the price is trading 4.0% below its 200 day moving average.
From a valuation standpoint, the stock is 73.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 18.4.
Mani, Inc's total revenue sank by 3.4% to $4B since the same quarter in the previous year.
Its net income has dropped by 6.3% to $984M since the same quarter in the previous year.
Based on the above factors, Mani, Inc gets an overall score of 1/5.
| Exchange | TSE |
|---|---|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| CurrencyCode | JPY |
| ISIN | JP3869920003 |
| Target Price | 1513.3334 |
|---|---|
| Dividend Yield | 3.8% |
| Beta | 0.18 |
| PE Ratio | 19.54 |
| Market Cap | 118B |
Mani, Inc. engages in the manufacture and distribution of medical devices and dental instruments in Japan and internationally. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, stainless wire needles, maniceps, septum stitch, and stent graft metal skeleton; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. In addition, the company imports and sells medical devices. The company was founded in 1956 and is headquartered in Utsunomiya, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 7730.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
